Tag - BMY

Developments

Bristol Myers Squibb to acquire TIAP’s Forbius

Bristol Myers Squibb (NYSE:BMY) entered a definitive agreement to acquire closely-held Forbius, a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and...

August 24, 2020

Developments

Repare Therapeutics in research collaboration with Bristol Myers

Closely-held Repare Therapeutics inked an exclusive, worldwide research collaboration with Bristol Myers Squibb (NYSE:BMY). Under the accord, the companies will leverage Repare’s CRISPR-enabled genome-wide synthetic...

May 28, 2020

Tag - BMY

Bristol Myers Squibb to acquire TIAP’s Forbius

Repare Therapeutics in research collaboration with Bristol Myers

General

More